Sage Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
12.07.24
/
50%
€10.63
Target price
12.07.25
€16.50
Performance (%)
-26.40%
End price
13.07.25
€7.82
Summary
This prediction ended on 13.07.25 with a price of €7.82. The price of Sage Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.40%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.760% | -0.301% | 17.507% |
| iShares Nasdaq 100 | 0.732% | -1.001% | 9.349% |
| iShares Nikkei 225® | 1.025% | -3.621% | 12.862% |
| iShares S&P 500 | -0.036% | -0.194% | 3.758% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at JPMorgan Chase & Co. from $23.00 to $18.00. They now have an "overweight" rating on the stock.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.99
20.06.24
20.06.24
€21.44
20.06.25
20.06.25
-20.83%
21.06.25
21.06.25
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.59
01.05.24
01.05.24
€26.21
01.05.25
01.05.25
-48.02%
02.05.25
02.05.25
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.20
26.03.24
26.03.24
€26.71
26.03.25
26.03.25
-54.16%
27.03.25
27.03.25